Epigral Limited
Epigral Limited, formerly known as Meghmani Finechem Ltd, incorporated in 2007, is a leading integrated manufacturer of chemicals in India. Epigral’s Dahej facility is a backward and forward integrated and automated complex with a well-planned infrastructure.
What Epigral files
- Investor Meet72
- Others48
- Important15
- Updates13
- Board Meeting9
- PPTs7
Epigral plans a new Epoxy Resin (125,000 TPA) & Multi-Purpose Plant at Dahej. This ~Rs 600 Cr expansion, by H2 FY2028, funded via debt/internal accruals, will diversify the portfolio and meet growing demand.
Epigral reported Q1 financial results with revenue at Rs 606.54 Cr, a decrease from Rs 651.20 Cr year-over-year. However, net profit surged to Rs 160.69 Cr, up from Rs 85.87 Cr, primarily due to a one-time deferred tax credit of Rs 80.87 Cr from adopting a new tax regime. The...
Epigral Ltd operates 14 domestic plants, exporting 6.6% of turnover across 15 countries, with full revenue from specialty chemicals. The company commits fully to sustainable R&D and invests 2.5% of capex in eco-friendly tech, sourcing over half of its inputs sustainably. Key projects include an 18.34 MW wind-solar hybrid JV,...
Epigral Limited has informed the Exchange about Execution of Share Subscription and Shareholder s Agreement and Energy Supply Agreement for Power purchase through renewable resources.
Epigral Limited has reclassified five erstwhile Promoter Group members as Public shareholders, reducing promoter holding and potentially boosting public float and stock liquidity. No changes to operations or financials reported.